drugset / Trial / NCT05839041
A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Investigate the Safety, Pharmacokinetics, and Treatment effects of Single and Multi-dose of Intravitreal AVD-104 in participants with geographic atrophy secondary to age-related macular degeneration.
Timeline
- Start
- 2023-05-02
- Primary completion
- 2026-04
- Completion
- 2026-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AVD-104 | Other / unclassified | — | Intravitreal |
| Comparator | Avacincaptad | Unknown | 2 mg | Intravitreal |